Affymetrix, MicroChips, Amersham Biosciences, Cartesian Technologies, Roche Diagnostics, Helix BioPharma | GenomeWeb

Affymetrix received US Patent No. 6,551,784, “Method of comparing nucleic acid sequences.” The patent covers a system for comparing and identifying differences in nucleic acid sequences and is an extension of the Santa Clara, Calif., company’s tract of intellectual property surrounding its methods of microarray analysis of gene expression. The company also received US Patent No. 6,551,817, “Method and apparatus for hybridization.” This patent covers a packaging system for a device containing probe molecules and methods for introducing fluids into it.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.